Bellerophon Therapeutics Inc (BLPH)
0.055
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Bellerophon Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2017 | 2.577M |
| September 30, 2017 | 4.048M |
| June 30, 2017 | 8.006M |
| March 31, 2017 | 12.95M |
| December 31, 2016 | 12.20M |
| September 30, 2016 | 10.06M |
| June 30, 2016 | -8.277M |
| Date | Value |
|---|---|
| March 31, 2016 | -16.60M |
| December 31, 2015 | -18.30M |
| September 30, 2015 | -17.82M |
| June 30, 2015 | -4.165M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Janux Therapeutics Inc | -41.19M |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |
| Theriva Biologics Inc | -0.202M |